31 completed, 19 unknown, 10 recruiting, 3 withdrawn. 68 Phase 3, 15 Phase 2.
Follow Standard care: new trials by email Literature Review of Standard care trials Research Report on Standard care
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial Plasma, Standard care - Burn Injury, Thermal Burn | Phase 3 | Recruiting | Jason Sperry | 750 | 2026-08-31 | 2026-11-16 |
| The ASPIRE Trial: AchilleS tendinoPathy Treated With cortIcosteRoid injEctions Standard care, Depo-Medrol (methylprednisolone acetate 40 mg) combined with lidocaine, placebo injections consisting of lidocaine only - Achilles Tendinopathy (AT) | Phase 3 | Recruiting | Erasmus Medical Center | 276 | 2026-06-03 | 2026-06-18 |
| Comparison of Early Pleural Irrigation Strategy With Saline to the Standard of Care for the Management of Complicated Pleural Infections. intrapleural irrigation, Standard care - Therapy, Pleural Infections | Phase 3 | Recruiting | Centre Hospitalier Universitaire, Amiens | 244 | 2026-05-13 | 2026-07-01 |
| Evaluation of Analgesia for Cardiac Elective Surgery in Children Methadone based ERAS, Non-methadone based group - Pediatric Cardiac Surgery | Phase 3 | Recruiting | Senthil Sadhasivam | 500 | 2025-12-17 | 2026-08-07 |
| Levosimendan in Acute Decompensated Heart Failure Levosimendan, Standard care - Acute Decompensated Heart Failure (ADHF) | Phase 2 / Phase 3 | Not yet recruiting | Chittagong Medical College | 332 | 2025-12-01 | 2025-12-04 |
| Impact of Varying Doses of Prucalopride on Improving Gut Function Recovery After Elective Colorectal Surgery Prucalopride 2mg, Prucalopride 4mg, Standard Care - Post-Op Complication | Phase 3 | Recruiting | Future University in Egypt | 180 | 2025-03-02 | 2025-03-19 |
| Empirical Intravenous Beta-Lactam Plus Metronidazole Vs Oral Cefixime Plus Metronidazole for the Treatment of Liver Abscess Intravenous beta-lactam antimicrobial for 2 weeks Plus Intravenous Metronidazole (750 mg q 8 hourly) for 2 weeks, Tablet Cefixime (200 mg q 12 hourly) for 2 weeks Plus Tablet Metronidazole (800 mg q 8 hourly) for 2 weeks, Standard medical care - Liver Abscess | Phase 3 | Recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 220 | 2025-02-25 | 2025-04-13 |
| An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM Rifampicin, Azithromycin, Isoniazid - Severe Acute Malnutrition, HIV | Phase 3 | Completed | Queen Mary University of London | 674 | 2024-07-15 | 2026-08-25 |
| Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial Alpha-ketoglutarate, Placebo, Standard care - Colorectal Cancer | Phase 3 | Unknown | National University Hospital, Singapore | 80 | 2024-05-09 | 2024-10-17 |
| V+PSF-M for Tobacco Cessation in HIV Care in India Varenicline, Positively Smoke Free Mobile (PSF-M), Standard Care - Human Immunodeficiency Virus, Smoking Cessation | Phase 3 | Recruiting | University of Colorado, Denver | 400 | 2024-01-02 | 2025-06-15 |
| Compare Oral Itraconazole and Standard Care Versus Standard Care Alone in Patients With Non-cystic Fibrosis Related Bronchiectasis With Chronic Aspergillus Infection in Reducing Bronchiectasis Exacerbations Itraconazole 65 MG, Standard care - Bronchiectasis, Bronchiectasis Adult | Phase 3 | Recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 80 | 2023-12-01 | 2026-10-26 |
| Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers ADRCs, standard care, Placebo - Diabetic Foot Ulcer | Phase 3 | Unknown | Paracrine, INC. | 290 | 2023-02-28 | 2022-09-28 |
| ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma ADRCs, Standard Care, Placebo - Scleroderma, Diffuse | Phase 3 | Unknown | Paracrine, INC. | 174 | 2023-02-28 | 2022-09-28 |
| Bevacizumab in Patients With Severe Covid-19 Bevacizumab, Placebo, Standard care - COVID-19 Pneumonia | Phase 3 | Unknown | Qilu Hospital of Shandong University | 588 | 2023-01-12 | 2023-06-27 |
| Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis 3% Sodium Chloride, Standard care - Acute Bronchiolitis | Phase 2 / Phase 3 | Completed | Can Tho University of Medicine and Pharmacy | 140 | 2022-06-01 | 2024-08-16 |
| Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy Atorvastatin, Standard Care - Neurocognitive Impairment, Mild | Phase 3 | Active not recruiting | The George Institute | 190 | 2022-03-10 | 2025-04-10 |
| Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial Cyproheptadine Hydrochloride 4 MG - Viral Pneumonia, Serotonin Syndrome | Phase 3 | Unknown | Ciusss de L'Est de l'Île de Montréal | 200 | 2021-04-10 | 2021-04-02 |
| Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 Hydroxychloroquine (HCQ), Standard care, Placebo - Covid19, COVID-19 Prevention | Phase 3 | Unknown | Post Graduate Institute of Medical Education and Research, Chandigarh | 1000 | 2021-03-22 | 2021-06-11 |
| Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care Metformin, Standard Care, Standardized meal - Diabetes, Bariatric Surgery | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 126 | 2021-01-07 | 2023-06-08 |
| Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II) TTAX01, Standard care - Diabetic Foot Infection, Non-healing Wound | Phase 3 | Completed | BioTissue Holdings, Inc | 106 | 2020-11-20 | 2025-04-01 |
Showing 20 of 68. Sign in to see all of them.
COVID-19 (11) · Acquired Immunodeficiency Syndrome (3) · Alcohol Drinking (2) · Coronavirus Infections (2) · Critical Illness (2) · Diabetes Mellitus (2) · HIV Infections (2) · Heart Failure (2) · Pneumonia, Viral (2) · Pulmonary Disease, Chronic Obstructive (2) · Smoking (2) · Smoking Cessation (2) · Stroke (2) · 22q11 Deletion Syndrome (1) · Acute Kidney Injury (1)
Post Graduate Institute of Medical Education and Research, Chandigarh (3) · BioTissue Holdings, Inc (2) · Hospital General Universitario Elche (2) · Paracrine, INC. (2) · Peking Union Medical College Hospital (2) · Tanta University (2) · Adelaide Institute for Sleep Health (1) · Assistance Publique - Hôpitaux de Paris (1) · Associazione Riabilitatori Insufficienza Respiratoria (1) · Australian and New Zealand Intensive Care Research Centre (1) · Bambino Gesù Hospital and Research Institute (1) · Boston Medical Center (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Can Tho University of Medicine and Pharmacy (1) · Centre Hospitalier Universitaire, Amiens (1)
United States (17) · China (7) · India (6) · Australia (4) · Brazil (4) · Canada (4) · Spain (4) · United Kingdom (4) · Bangladesh (2) · Colombia (2) · Egypt (2) · France (2) · Germany (2) · Italy (2) · Kenya (2)
Adriaan Kooy, MD (1) · Alberto Ortiz, MD (1) · Alisha Maslanka, BS (1) · Andreas Birkenfeld, MD (1) · Bertram Pitt (1) · Carolina Llavero (1) · Christian Delles, MD (1) · Craig Anderson, MD (1) · Elizabeth Lloyd-Richardson, PhD (1) · Eric Adehossi (1) · Fazle R Chowdhury, FCPS (1) · Gerjan Navis, MD (1) · Gina Kruse, MD (1) · Goce Spasovski, MD (1)
PMID 1593279, PMID 19719796, PMID 19752419, PMID 19752420, PMID 21599896, PMID 21664068, PMID 22388536, PMID 22732470, PMID 23130740, PMID 23218847, PMID 23229691, PMID 23276300, PMID 23320022, PMID 23490572, PMID 24045740, PMID 24293768, PMID 25187211, PMID 25219686, PMID 25358424, PMID 25524751, PMID 25669180, PMID 26086920, PMID 26246593, PMID 26423375, PMID 26685116, PMID 26703919, PMID 26936907, PMID 27008910, PMID 27044249, PMID 27215559, PMID 27571048, PMID 28551445, PMID 28743190, PMID 28970100, PMID 29316883, PMID 29349539, PMID 29361959, PMID 29781558, PMID 30268694, PMID 31023272, PMID 31442620, PMID 31587046, PMID 31808921, PMID 32013799, PMID 32135136, PMID 32142651, PMID 32248771, PMID 32282022, PMID 32291275, PMID 32313880
2019 (1), 2025 (1), P60AA013759 (1), R01CA148707 (1), U01CA261614 (1), U01HD116257 (1), U01HL134679 (1), U01HL134694 (1), U10EY014351 (1), U10EY014352 (1), U10EY014404 (1)